Chronic administration of aluminium l-glutamate in young mature rats: Effects on iron levels and lipid peroxidation in selected brain areas

Toxicology Letters

Volumn 104, Issue 1-2, 1999, Pages 65-73

  Deloncle, Roger ^a,b   Huguet, François ^a   Babin, Philippe ^c   Fernandez, Beatrice ^c   Quellard, Nathalie ^c   Guillard, Olivier ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Aluminium; Brain; Iron; L glutamic acid; Lipid peroxidation; Polyunsaturated fatty acids; Thiobarbituric acid reactive substances

Indexed keywords

ALUMINUM; ALUMINUM DERIVATIVE; GLUTAMIC ACID; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; DRUG TISSUE LEVEL; IRON BLOOD LEVEL; LIPID PEROXIDATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALUMINUM; ANIMALS; BRAIN CHEMISTRY; CEREBRAL CORTEX; FATTY ACIDS, UNSATURATED; GLUTAMATES; HIPPOCAMPUS; IRON; LIPID PEROXIDATION; MALE; NEOSTRIATUM; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0032963619     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00345-2     Document Type: Article

References (54)

1. Aisen P. Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin. Ann. Neurol. 32(Suppl.):1992;S56-S58.
2. Alfrey A.C., Legendre G.R., Kaehny W.D. The dialysis encephalopathy syndrome. Possible aluminium intoxication. New Engl. J. Med. 294:1976;184-188.
3. Banks W.A., Kastin A.J. Aluminum increases permeability of the blood brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia. Lancet. ii:1983;1227-1229.
4. Berlyne G.M., Yagil R., Ben Ari J., Weinberger G., Knopf E., Danovitch G.M. Aluminium toxicity in rats. Lancet. 1:1972;564-568.
5. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
6. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Cannata J.B., Suarez C., Rodriguez C.et al. Assessing the benefit of changing aluminum hydroxide schedule on anemia and serum phosphorus control. Proc. Eur. Dial. Transplant Ass. 21:1984;10-13.
8. Cohen, G., 1988. Oxygen radical and Parkinson's disease. In: Halliwell R. (Ed.), Oxygen Radical and Tissue Injury. FASEB, Bethesda, pp. 130-135.
9. Connor J.R., Fine R.E. The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res. 368:1986;319-328.
10. Connor J.R., Menzies S.L., St. Martin S., Mufson E.J. The cellular distribution of transferrin, ferritin and iron in the human brain. J. Neurosci. Res. 27:1990;595-611.
11. Deloncle R., Guillard O. Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication. Neurochem. Res. 15:1990;1239-1245.
12. Deloncle R., Guillard O., Clanet F., Courtois P., Piriou A. Aluminium transfer as glutamate complex through blood-brain barrier. Possible implication in dialysis encephalopathy. Biol. Trace Elem. Res. 25:1990;39-45.
13. Deloncle R., Guillard O., Huguet F., Clanet F. Modification of the blood-brain barrier through chronic intoxication by aluminium glutamate. Biol. Trace Elem. Res. 47:1995;227-233.
14. Evans P.H., Peterhans E., Bürge T., Klinowsky J. Aluminosilicate-induced free radical generation by murine brain glial cells in vitro: potential significance in the aetiopathogenesis of Alzheimer's dementia. Dementia. 3:1992;1-6.
15. Exley C., Birchall J.D. The cellular toxicity of aluminium. J. Theor. Biol. 159:1992;83-98.
16. Fernandez-Menendez M.J., Olaizola I.R., Diaz-Lopez J.B., Fernandez-Soto I., Roza M., Cannata J.B. A double risk of aluminium hydroxide: increased aluminum uptake and reduced iron absorption. Trace Elem. Med. 8:1991;167-171.
17. Fleming J., Joshi J.G. Ferritin: isolation of aluminium-ferritin complex from brain. Proc. Natl. Acad. Sci. USA. 84:1997;7866-7870.
18. Florence A., Struys-Ponsar C., Gauthier A., Crichton R.R., Van den Bosch de Aguilar P. An experimental animal model of aluminium overload. Neurodegeneration. 3:1993;315-323.
19. Fraga C.G., Oteiza P.I., Golub M.S., Gershwin M.E., Keen C.L. Effects of aluminium on brain lipid peroxidation. Toxicol. Lett. 51:1990;213-219.
20. Guillard O., Tiphaneau K., Reiss D., Piriou A. Improved determination of aluminium in serum by electrothermal atomic absorption spectrometry and Zeeman background correction. Anal. Lett. 17B:1984;1593-1605.
21. Gutteridge J.M.C., Quinlan G.J., Clark I., Halliwell B. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim. Biophys. Acta. 835:1985;441-447.
22. Hill J.M., Switzer R.C. The regional distribution and cellular localisation of iron in the rat brain. Neuroscience. 11:1984;595-603.
23. Hill, J.M., 1988. The distribution of iron in the brain. In: Youdim M.B. (Ed.), Brain Iron: Neurochemical and Behavioral Aspects, vol.2. Taylor and Francis, London, pp. 1-24.
24. Huguet F., Deloncle R., Guillard O., Ingrand P., Piriou A. In vitro and in vivo effects of aluminium L-glutamate complex on dopamine accumulation in rat hippocampal slices. Pharmacol. Toxicol. 47:1993;57-59.
25. Jeffery E.H. Biochemical mechanisms of aluminium toxicity. Handb. Exp. Pharmacol. 115:1994;139-162.
26. Johnson G.V.W., Jope R.R. Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain. Res. 403:1987;1-6.
27. Katsetos C.D., Savory J., Herman M.M.et al. Neuronal cytoskeletal lesions induced in the central nervous system by intraventricular and intravenous aluminium maltol in rabbits. Neuropathol. Appl. Neurobiol. 16:1990;511-528.
28. Klatzo I., Wisniewski H., Streicher E. Experimental production of neurofibrillary degeneration. J. Neuropathol. Expl. Neurol. 24:1965;187-199.
29. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
30. Landsberg J.P., Mc Donald B., Watt F. Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature. 360:1992;65-68.
31. Markesberry W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Rad. Biol. Med. 23:1997;134-147.
32. 3+. Clin. Chem. 33:1987;405-407.
33. Mash D.C., Pablo J., Buck B.E., Sanchez-Ramos J., Weiner W.J. Distribution and number of transferrin receptor in Parkinson's disease and in MPTP-treated mice. Exp. Neurol. 114:1991;73-81.
34. Minotti G., Aust S.D. The requirement for iron(III) in the initiation of lipid peroxidation by iron(II) and hydrogen peroxide. J. Biol. Chem. 262:1987;1098-1104.
35. Mitsumoto H., Hanson M.R., Chad D.A. Amyotrophic lateral sclerosis: recent advances in pathogenesis and therapeutic trials. Arch. Neurol. 45:1988;189-202.
36. Mizuno Y., Ohta K. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J. Neurochem. 46:1986;1344-1352.
37. 3H]glutamate-binding sites in rat brain. J. Neurosci. 5:1985;2909-2919.
38. Octave J.N., Schneider Y.J., Trouet A., Crichton R.R. Iron uptake and utilization by mammalian cells. I: cellular uptake of transferrin and iron. Trends Biochem. Sci. 8:1983;217-220.
39. Oteiza P.I. A mechanism for the stimulatory effect of aluminium on iron-induced lipid peroxidation. Arch. Biochem. Biophys. 308:1994;374-379.
40. Oteiza P.I., Fraga C., Keen C.L. Aluminium has both oxidant and antioxidant effects in mouse brain membranes. Arch. Biochem. Biophys. 300:1993;517-521.
41. Pineau A., Guillard O., Chappuis P., Arnaud J., Zawislak R. Sampling conditions for biological fluids for trace element monitoring in hospital patients: a critical approach. Crit. Rev. Clin. Lab. Sci. 30:1993;203-222.
42. Renard J.L., Felten D., Bequet D. Post-otoneurosurgery aluminium encephalopathy. Lancet. 344:1994;63-64.
43. Riederer P., Sofic E., Rausch W.D.et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brain. J. Neurochem. 52:1989;515-520.
44. Rosen D.R., Siddique T., Figlewicz D.A., Sapp P.et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateralsclerosis. Nature. 362:1993;59-62.
45. Sanderson C.L., Crapper McLachlan D.R., DeBoni U. Altered steroid induced puffing by chromatin bound aluminium in a polytene chromosome of the black fly, similium vittatum. Can. J. Genet. Cytol. 24:1982;27-36.
46. Sanfeliu C., Hunt A., Patel A. Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res. 526:1990;241-248.
47. Sarkander, H., Balb, G., Schlösser, R., Stoltenburg, G., Lux, R.M., 1983. Blokade of neuronal brain RNA initiation sites by aluminium: a primary molecular mechanism of aluminium- induced neurofibrillary changes? In: Cervos-Navarro, J., Sarkander, H.I. (Eds.), Brain Aging: Neuropathology and Neuropharmacology. Raven Press, New York, pp. 259-274.
48. Skinner E.R., Watt C., Besson J.A.O., Best P.V. Differences in the fatty acid composition of the grey and white matter of different regions of the brain of patients with Alzheimer's disease and control subjects. Brain. 116:1993;717-725.
49. Van Ginkel M.F., Van der Voet G.B., de Wolff F.A. Improved method of analysis for aluminium in brain tissue. Clin. Chem. 36:1990;658-661.
50. Van Rensburg S.J., Carstens M.E., Potocnik F.C.V., Aucamp A.K., Taljaard J.J., Koch K.R. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes. Neurochem. Res. 17:1992;825-829.
51. 2+ uptake in acutely dissociated brain cells derived from adult rats. Brain Res. 570:1992;347-353.
52. Xie C.X., Yokel R.A. Aluminum facilitation of iron-mediated lipid peroxidation is dependent on substrate, pH and aluminum and iron concentrations. Arch. Biochem. Biophys. 327:1996;222-226.
53. Xie C.X., Pyrek J.S., Porter W.H., Yokel R.A. Hydroxyl radical generation in rat brain is initiated by iron but not aluminium, as determined by microdialysis with salicylate trapping and GC-MS analysis. Neurotoxicology. 16:1995;489-496.
54. Yagi K. A simple fluorometric assay for lipoperoxide involved in blood plasma. Biochem. Med. 15:1976;212-216.